Accelevir Diagnostics

About:

Accelevir Diagnostics is a biotechnology company develops assays for ultra-rare analytes in infectious diseases.

Website: https://accelevirdx.com

Top Investors: National Science Foundation

Description:

Accelevir Diagnostics is a biotech-based industry. They provide clinical researches like unparalleled virology and infectious disease expertise to clinical, biotech, pharmaceutical, public health, academic, and diagnostic partners. They provide scientifically-driven custom services. They include digital PCR, single-target culture techniques, fidelity sequencing, and data-driven analytics.

Total Funding Amount:

$1.42M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)accelevir.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2017-09-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai